Insider · CIK 0001620548
Luis C. Pena
Files at EVMN (Evommune, Inc.). First filing Jun 3, 2026, latest Jun 24, 2026.
Luis C. Pena files SEC Form 4 as CEO, president and director at EVMN (Evommune, Inc.). Since Jun 3, 2026, Luis C. Pena has reported 0 open-market buys worth $0 and 2 open-market sells worth $551k, the latest filed on Jun 24, 2026.
A track record needs three past buys with six months of prices behind them; Luis C. Pena has 0, so none is measured yet.
The newest scored trade: sold $169k of EVMN on Jun 22, 2026, filed Jun 24, 2026, scored 31 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $551k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVMN: Evommune, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Evommune, Inc. | $169k 7,438 shares | -1% | +50% from low-29% from high | |
| 36Weak | Evommune, Inc. | $382k 16,787 shares | -3% | +48% from low-30% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 1, 2026 | EVMN Evommune, Inc. | 24,225 0.07% of outstanding | $563k | Jun 1, 2026 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | EVMN Evommune, Inc. | SOpen-market sale Common Stock10b5-1 | -7,438 | $22.71 | $169k | 630,458 | Jun 24, 2026 |
| Jun 1, 2026 | EVMN Evommune, Inc. | SOpen-market sale Common Stock10b5-1 | -16,787 | $22.74 | $382k | 637,896 | Jun 3, 2026 |
| Apr 16, 2026 | EVMN Evommune, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +291,420 | $0.00 | $0 | 291,420 | Apr 17, 2026 |
| Dec 9, 2025 | EVMN Evommune, Inc. | FTax withholding Common Stock | -28,138 | $17.84 | $502k | 654,683 | Dec 11, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Common Stock | +24,225 | - | - | 682,821 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series Seed Preferred Stockderivative | -206,355 | - | - | 0 | Nov 12, 2025 |
| Nov 5, 2025 | EVMN Evommune, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +796,841 | $0.00 | $0 | 796,841 | Nov 7, 2025 |
Questions about Luis C. Pena
Answered from the filings on this page, as of the latest one.
Is Luis C. Pena buying or selling?
In the last 12 months Luis C. Pena reported 0 open-market buys worth $0 and 2 open-market sells worth $551k on SEC Form 4; the latest was sold $169k of EVMN on Jun 22, 2026. Grants, option exercises and tax withholding are not counted.
How did Luis C. Pena's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Luis C. Pena has 0.
Where does Luis C. Pena file Form 4?
Luis C. Pena has filed Form 4 at EVMN (Evommune, Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.